Tag: Lexaria Biosciences
Lexaria to Highlight its DehydraTECH(TM) Technology at Four Upcoming Investor Conferences
Lexaria Bioscience Sells Non-Pharmaceutical THC-Related Assets for CDN$3.85M
Lexaria Bioscience Advances 2021 Strategic Initiatives
Lexaria Proprietary DehydraTECH-Enabled CBD Powders Business Growing Faster than ExpectedGrowth now expected to exceed 500% from fiscal Q4 2020 to fiscal Q1 2021
Lexaria Bioscience Granted First European Patent for DehydraTECH Technology
Molecule Signs Agreement with Hill Street Beverage Company Inc. to Produce Cannabis Infused Beverages
